Demineralized Allografts Market grows with rapidly aging population and increasing obesity rates17Nov
Bone grafts are generally utilized for bone regeneration, pain relief and structure restoration for decades all over the world. Conservatively, autografts were used for bone grafting, in which patient’s own bone was used as a graft. Autologous bone grafts have proven very useful and is recognized as a gold standard for bone transplant. On the contrary, use of autologous bone grafts embraces the risk of infection transfer. This infection transfer during surgical procedures at both tissue harvesting and transplant sites results in late wound healing and prolonged hospital stay. Therefore, allografts were introduced in the market for overcoming the disadvantages associated with autologous grafts. Allografts possess both osteoinductive and osteoconductive properties, and hence serve as a worthy substitute for autografts.
Demineralized bone allografts are also referred as DBMs. Two methods introduced for processing of donor tissue to obtain Demineralized Bone Matrix (DBM) include:
Grinding the bones into particulate powder
Milling the bones into fibers
DBMs that employ fibers exhibit better osteoconductive scaffold because of their interwoven structure. This interwoven structure gives bone forming cells an opportunity to migrate within the matrix instead of trying to “jump” the gaps between the particles. Demineralized Bone Matrix which uses the fiber technology are engineered in such a way that enhances their properties like osteoconduction. This property is very essential for the quicker healing of the orthopedic tissues after surgery.
Allografts comprise the tissues, cells and/or proteins that are utilized for implantation, infusion or transplant from donor to the recipient with different genetic makeup of the same species. DBM is the human bone processed with hydrochloric acid that removes the mineral content of the bone. After processing collagen, bone proteins and bone morphogenetic proteins are left. These demineralized allografts exhibit high osteoinductive properties alongside some osteoconductive properties with structural support. Demineralized allografts are readily available world over and are very popular substitutes of the bone autografts. These demineralized bone matrix is often combined with cortical and cancellous bone chips to improve osteoconductive properties. These can be utilized as autologous bone grafts extender in spinal and trauma surgeries. DBM is generally regulated by FDA’ 510K marketing clearing processes. Demineralized allografts if not combined with other materials then only it can be utilized for transplantation. Growth in demineralized allograft market is greater due to anticipated surge in soft-tissue allografts. Increasing demand for repair procedures related to growth in more active lifestyles among affluent younger people. The demineralized allograft market is expected to grow at huge CAGR because of new technological innovations in grafting, and increase in cosmetic surgery, etc. Zimmer has introduced Puros, a demineralized bone matrix which contains ground cortical cancellous chips from the donors.
More information: http://www.transparencymarketresearch.com/
If you would like more information or would like us to
contact you please fill in the form below and we will respond promptly.
11503 NW Military Hwy, Suite 307
San Antonio, TX 78231
P: (877) 781-4406
F: (877) 292-9353